Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-01-03FDA Approved: SYMLINPEN — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for SYMLINPEN (pramlintide acetate) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2011-10-30FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly, including the diluent, indicating regulatory approval of chan…
-
FDA approval · 2011-10-30FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2011-10-30FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved Eli Lilly's supplemental application for Humalog Mix50/50 KwikPen (insulin lispro). The approval pertains to the Humalog Mix50/…
-
FDA approval · 2011-10-30FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) from Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-05-18FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, reflecting a labeling or formulation update under the supplementa…
-
FDA approval · 2010-12-27FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN R (human insulin) submitted by Novo Nordisk.
-
FDA approval · 2010-06-10FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) filed by Eli Lilly and Company.
-
FDA approval · 2010-01-22FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk. The approval pertains to the supplemental submissio…
-
FDA approval · 2009-07-17FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLOG (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2009-07-17FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) from Novo Nordisk. The approval updates the labeling/indication fo…
-
FDA approval · 2009-07-17FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) submitted by Novo Nordisk.
-
FDA approval · 2009-06-15FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
-
FDA approval · 2009-06-15FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN 70/30 insulin, manufactured by Novo Nordisk.
-
FDA approval · 2009-05-07FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Novo Nordisk's NovoLog (insulin aspart).
-
FDA approval · 2009-05-07FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2009-03-16FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly and Company. The approval updates the product's labeling and/o…
-
FDA approval · 2009-03-16FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company. The action updates the pro…
-
FDA approval · 2009-02-24FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) from Sanofi U.S. LLC, resulting in an updated label for the product.
-
FDA approval · 2008-11-28FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2008-11-28FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2008-11-28FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA approved a supplemental application for Insulin aspart protamine and insulin aspart mix 70/30 (Novo Nordisk) to continue marketing this …
-
FDA approval · 2008-10-24FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) from Sanofi-aventis U.S. LLC.
-
FDA approval · 2008-09-03FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2008-05-01FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company.